Viewing Study NCT05366166


Ignite Creation Date: 2025-12-24 @ 4:40 PM
Ignite Modification Date: 2026-01-02 @ 6:33 AM
Study NCT ID: NCT05366166
Status: RECRUITING
Last Update Posted: 2025-04-23
First Post: 2022-05-04
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Pembrolizumab Plus Olaparib in LA-HNSCC
Sponsor: UNC Lineberger Comprehensive Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module